Adriana K Calapaquí Terán

8PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersMolecular targetsImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 27, 2026
Centralized Homologous Recombination Repair Testing in Metastatic Castration-Resistant Prostate Cancer: Real-World Data from a Multicenter Spanish Precision Oncology Program.

|Mar 12, 2025
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?

Irene García Megías, Ludmila Santiago Almeida, Adriana K Calapaquí Terán

|Oct 25, 2024
Assessment of the therapeutic efficacy of [177Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

Ludmila Santiago Almeida, Irene García Megías, Elba Cristina Sá Camargo Etchebehere

|Mar 24, 2023
A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer.

Roberto C Delgado Bolton, Adriana K Calapaquí Terán, José Javier Gómez Román

|Feb 08, 2023
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?

Roberto C Delgado Bolton, Adriana K Calapaquí Terán, Ken Herrmann

|Dec 29, 2022
Is there more than meets the eye than sentinel node localisation during lymphoscintigraphy mapping? Potential immunologic and therapeutic implications.

Roberto C Delgado Bolton, Adriana K Calapaquí Terán, Giorgio Treglia

Pageof 2

Frequent Collaborators

7 joint publications

Roberto C Delgado Bolton

7 joint publications

Francesco Giammarile

3 joint publications

Ken Herrmann

3 joint publications

Giorgio Treglia